5608 Results

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. Solit
    Solit
  4. Morris
    Morris
  5. Bajorin
    Bajorin
  6. Rosenberg
    Rosenberg
  7. Berger
    Berger
  8. Iyer
    Iyer
  9. Reuter
    Reuter
  10. Feldman
    Feldman

Groups

  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)
  7. Surgery (1000)
  8. Epidemiology and Biostatistics (864)
  9. Survivorship Research (773)
  10. Urology (769)
  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genetic and pharmacological inhibition of p13 kinase signaling in vivo sensitizes tumors to EGFR inhibitors and to taxol
    Meeting Abstract

    She, Q. B.; Ye, Q.; She, Y. H.; Solit, D.; Gibbons, J.; Rosen, N.
    Clinical Cancer Research (2005)

    Fulltext@MSK | Save
  • Protein and DNA-based vaccines with the NY-ESO-1 antigen in cancer patients
    Meeting Abstract

    Sharma, P.; Bajorin, D. F.; Altorki, N. K.; Nishikawa, H.; Old, L. J.; Gnjatic, S.
    Journal of Immunotherapy (2005)

    Fulltext@MSK | Save
  • A phase I/II trial to assess tolerability and efficacy of RAD-001 with gefitinib in patients with glioblastoma multiforme and castrate metastatic prostate cancer
    Meeting Abstract

    Shaffer, D. R.; Abrey, L.; Beekman, K.; Morris, M.; Eicher, C.; Kelly, W. K.; Slovin, S.; Solit, D.; Rosen, N.; Scher, H. I.
    EJC Supplements (2005)

    Fulltext@MSK | Save
  • Androgen deprivation therapy for biochemical recurrence in patients with seminal vesicle invasion after radical prostatectomy
    Meeting Abstract

    Secin, F. P.; Bianco, F. J.; Vickers, A. J.; Sogani, P.; Scher, H. I.; Scardino, P. T.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Results of nephrectomy for patients with metastatic renal cancer
    Meeting Abstract

    Russo, P.; Saranchuk, J.; Touijer, K.; Snyder, M. E.; Drucker, B.; Motzer, R.
    Annals of Surgical Oncology (2005)

    Fulltext@MSK | Save
  • The revised Memorial Anxiety Scale for Prostate Cancer (MAX-PC-R): Validation of a scale to measure anxiety in men with prostate cancer
    Meeting Abstract

    Roth, A. J.; Nelson, C. J.; Rosenfeld, B.; Warshowsky, A.; O'Shea, N.; Scher, H. I.; Breitbart, W.; Holland, J. C.; Curley-Smart, T.; Reynolds, T.
    Psycho-Oncology (2005)

    Fulltext@MSK | Save
  • Reverse transcriptase polymerase chain reaction for prostate-specific antigen (RT-PCR PSA) responses may predict time to progression (TTP) in hormone refractory prostate cancer (HRPC) patients treated with chemotherapy
    Meeting Abstract

    Ross, R. W.; Manola, J.; Hennessy, K.; Galsky, M.; Scher, H.; Small, E.; Kelly, W. K.; Kantoff, P.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Treatment outcome and incidence for late relapse of germ cell tumor (GCT) patients (pts): The Memorial Sloan-Kettering Cancer Center (MSKCC) experience
    Meeting Abstract

    Ronnen, E. A.; Kondagunta, G. V.; Bacik, J.; Marion, S.; Bajorin, D. F.; Sheinfeld, J.; Bosl, G. J.; Motzer, R. J.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • AG-013736, a multi-target tyrosine kinase receptor inhibitor, demonstrates anti-tumor activity in a Phase 2 study of cytokine-refractory, metastatic renal cell cancer (RCC)
    Meeting Abstract

    Rini, B.; Rixe, O.; Bukowski, R.; Michaelson, M. D.; Wilding, G.; Hudes, G.; Bolte, O.; Steinfeldt, H.; Reich, S. D.; Motzer, R.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • A phase I clinical and pharmacokinetic study of weekly docetaxel followed by flavopiridol: Promising activity in metastatic pancreatic cancer
    Meeting Abstract

    Rathkopf, D.; Fornier, M.; Shah, M. A.; Kortmansky, J.; O'reilly, E.; Winkelmann, J.; Balzano, L.; Kelsen, D. P.; Schwartz, G. K.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save